MFG
TEVA icon

MidWestOne Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

MidWestOne Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$345K Buy
+11,046
New +$272K 0.04% 231

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

MidWestOne Financial Group's TEVA Position: Q4 2025 in Review

MidWestOne Financial Group opened a new position in Teva Pharmaceuticals (TEVA) in Q4 2025: 11,046 shares worth $345K. The stake represents 0.04% of the portfolio and ranks #231 among its holdings.

631 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

  • MidWestOne Financial Group held 11,046 shares of Teva Pharmaceuticals worth $345K as of Q4 2025.
  • Teva Pharmaceuticals was a new MidWestOne Financial Group position in Q4 2025.
  • Teva Pharmaceuticals made up 0.04% of MidWestOne Financial Group's portfolio in Q4 2025, its #231 holding.
  • 631 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2025.

Based on MidWestOne Financial Group's 13F filing for Q4 2025, filed 12 Feb 2026.